Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion type Assertion NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_head.
- NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion description "[Other narcoleptic markers also frequently found in patients without narcolepsy included ESS>14 (78% of 27 patients), UNS>14 (75%), REM symptoms (30%), sleep latencies on MSLT<5 min (41%), >/=2 SOREM (30%), DQB1*0602 positivity (52%), BMI>25 (52%), and increased CSF leptin (48%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_provenance.
- NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion evidence source_evidence_literature NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_provenance.
- NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion SIO_000772 14592354 NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_provenance.
- NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion wasDerivedFrom befree-20140225 NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_provenance.
- NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_assertion wasGeneratedBy ECO_0000203 NP731685.RAAqsjOmvgAkmUvyF5EdCarrxYk5hbW8zLl1aiZKlGE-c130_provenance.